Postural orthostatic tachycardia syndrome treatment guidelines
|
Postural orthostatic tachycardia syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Postural orthostatic tachycardia syndrome treatment guidelines On the Web |
|
American Roentgen Ray Society Images of Postural orthostatic tachycardia syndrome treatment guidelines |
|
FDA on Postural orthostatic tachycardia syndrome treatment guidelines |
|
CDC on Postural orthostatic tachycardia syndrome treatment guidelines |
|
Postural orthostatic tachycardia syndrome treatment guidelines in the news |
|
Blogs on Postural orthostatic tachycardia syndrome treatment guidelines |
|
Directions to Hospitals Treating Postural orthostatic tachycardia syndrome |
|
Risk calculators and risk factors for Postural orthostatic tachycardia syndrome treatment guidelines |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
ACC/AHA/ESC Practice Guidelines. Recommendations for Treatment of Postural Orthostatic Tachycardia Syndrome[1] (DO NOT EDIT)
| “ |
Class IIaMedical
1) Increase salt and fluid intake (Level of Evidence: B) 2) Head-up tilt sleep (Level of Evidence: B) 3) Physical maneuvers (Level of Evidence: B) 4) Compression stockings (Level of Evidence: B)
1) Mineralocorticoids: Fludrocortisone (Level of Evidence: B) 2) Beta blockers: Bisoprolol (Level of Evidence: B) 3) Beta Blockers plus mineralocorticoids: Bisoprolol plus Fludrocortisone (Level of Evidence: B) Class IIb
1) Central sympatholytic agents: Clonidine (Level of Evidence: B) 2) Peripherally acting: Midodrine (Level of Evidence: B) 3) Centrally acting: Methylphenidate (Level of Evidence: C) 4) Serotonin-specific reuptake inhibitor: Fluoxetine (Level of Evidence: C) 5) Others: Erythropoietin (Level of Evidence: B), Ergotamine/octroetide (Level of Evidence: B), Phenobarbitone (Level of Evidence: C) Class IIIInterventional
1) Sinus node modification, catheter ablation (Level of Evidence: B)
|
” |
References
- ↑ Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ (2003). "ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society". Journal of the American College of Cardiology. 42 (8): 1493–531. PMID 14563598. Retrieved 2012-09-12. Unknown parameter
|month=ignored (help)